An FDA advisory panel concludes that the efficacy of brexpiprazole, when started concurrently with sertraline, has not been ...

This summary covers significant health news including FDA advisers rejecting Otsuka's PTSD treatment, Getinge exceeding ...

The FDA panel voted against Otsuka's PTSD drug combination with Zoloft, questioning its efficacy. Getinge surpassed profit ...

The controversial drugs are not yet approved by federal regulators, but advocates hope a NC law would allow the state to be ...

A U.S. Food and Drug Administration (FDA) advisory panel has voted overwhelmingly against the approval of Otsuka ...

Otsuka and Lundbeck’s data are insufficient to establish significant efficacy of Rexulti plus sertraline in PTSD, according ...

Proponents of reining in the largely unregulated intoxicating hemp industry in Texas shared new polling data on Wednesday ...

Market is valued at USD 10.25 Billion in 2024 and is projected to reach a value of USD 610.1 Billion by 2035 at a CAGR ...

As the Texas legislature convenes for a special session this week, members have so far introduced a number of bills that ...

Moderna has scrapped plans to build an mRNA plant in Japan. Otsuka and Lundbeck's proposal for Rexulti as part of a PTSD ...

Pharmaceutical tariffs are coming, part of President Trump’s stated goal of bringing drug manufacturing back to the U.S.

Now, a new study brings another breakthrough discovery suggesting a significant anti-aging potential of one ingredient found ...